| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to cardiology, and can be used in predicting the development of metabolic syndrome in male arterial hypertension. The patient with arterial hypertension is examined for biomedical measurements including cell membrane stability and predicted level of metabolic syndrome by following formula: ^ where K is a prognostic coefficient, CMS is cell membrane stability (sec), LDLPCL is low-density lipoproteid cholesterol (mmol/l), CL is total cholesterol (mmol/l), HDLPCL is high-density lipoproteid cholesterol (mmol/l). The Këñ1.2 allows predicting high probability of metabolic syndrome development in male arterial hypertension, the KëÑ2.5 shows low probability of metabolic syndrome in male arterial hypertension, and in case of 1.2<K<2.5, average probability of male arterial hypertension is predicted. ^ EFFECT: development of exact prediction procedure for metabolic syndrome development. ^ 2 ex |
